Abstract:BackgroundThromboembolic events are leading causes of mortality and morbidity all over the world. Tongmai (TM) is a botanical drug with valid clinical efficacy and safety in the management of thrombosis and ischemic cardiovascular diseases, however, its active compounds and underlying mechanism are largely unclear.PurposeTo investigate the endogenous effects, therapeutic mechanism and active compounds of TM in thrombus formation.Study designCombined with transgenic zebrafish models and high-content imaging system, this study evaluated the endogenous antithrombotic effects of TM and screened for the active compounds.MethodsThe PHZ-induced thrombotic model in erythrocytes or platelets labeled transgenic zebrafish were established, to dynamically evaluate the antithrombotic effects of TM. The oxidative damage levels were analyzed by specific fluorescent probes, and the expression levels of key factors in coagulation cascades and platelet activation were examined by QPCR. TM were dissected into fractions by reverse phase chromatography and subsequently screened for their antithrombotic effects in the transgenic fish models. The compounds of the active TM fraction were then analyzed by UPLC-Q-TOF analysis and further verified for their antithrombotic effects and mechanisms.ResultsIn PHZ-induced zebrafish thrombotic model, TM incubation markedly increased cardiac blood flow, decreased peripheral erythrocytes aggregation, and recovered peripheral platelet circulation. Besides, the levels of oxidative stress and lipid peroxidation were increased in the PHZ-induced thrombotic fish, which were greatly decreased by TM treatment. Moreover, TM significantly reduced the expression of coagulation factor II (thrombin) and the downstream fibrinogen. In order to identify the active compounds of TM, four fractions were separated from the extract by reverse phase chromatography, which were subsequently screened for their antithrombotic effects in the fish model. As a result, fraction 4 showed the strongest effect in inhibiting thrombosis. Finally, through UPLC-Q-TOF analysis and endogenous screening, cryptotanshione was identified as the main active compound with antithrombotic effects.ConclusionOur study demonstrated the endogenous antithrombotic effects of TM, which is possibly mediated by inhibiting oxidative stress and coagulation cascade. Cryptotanshione was identified as a major compound with antithrombotic activity and is a promising candidate for novel antithrombotic therapy.

Tetramethylpyrazine Protects Endothelial Injury and Antithrombosis via Antioxidant and Antiapoptosis in HUVECs and Zebrafish

Identification of Cryptotanshinone from Tongmai to Inhibit Thrombosis in Zebrafish Via Regulating Oxidative Stress and Coagulation Cascade.

Inhibition Of Angiogenesis, Fibrosis And Thrombosis By Tetramethylpyrazine: Mechanisms Contributing To The Sdf-1/Cxcr4 Axis

Protective effect of tetramethylpyrazine on vascular endothetial cell injured by hydrogen peroxide

TMPDP, a tetramethylpyrazine derivative, protects vascular endothelial cells from oxidation damage by hydrogen peroxide.

Tetramethylpyrazine Protects CoCl2-induced Apoptosis in Human Umbilical Vein Endothelial Cells by Regulating the PHD2/HIF/1α-VEGF Pathway.

Tetramethylpyrazine Alleviates Endothelial Glycocalyx Degradation and Promotes Glycocalyx Restoration via TLR4/NF-κB/HPSE1 Signaling Pathway During Inflammation

Protective Effect of Tetramethylpyrazine Hydrochloride on Endothelial Cell Injury Induced by Angiotensin Ⅱ

Tetramethylpyrazine Alleviates Iron Overload Damage in Vascular Endothelium Via Upregulating DDAHII Expression

Tetramethylpyrazine Ameliorates High Glucose-Induced Endothelial Dysfunction By Increasing Mitochondrial Biogenesis

Tetramethylpyrazine Alleviates LPS-induced Inflammatory Injury in HUVECs by Inhibiting Rho/ROCK Pathway

Tetramethylpyrazine alleviates mitochondrial abnormality in models of cerebral ischemia and oxygen/glucose deprivation Reoxygenation

Integrated investigation of lipidome and related signaling pathways uncovers molecular mechanisms of tetramethylpyrazine and butylidenephthalide protecting endothelial cells under oxidative stress.

Protective Effect of Tetramethylpyrazine Against Damages of Aortic Endothelial Cells Elicited by Low-Density Lipoproteins.

Effect of Tetramethylpyrazine on Hypoxic Model in Human Umbilical Vein Endothelium Cells and Its Functions of Anticoagulation and Fibrinolysis

Tetramethylpyrazine Inhibits Agiontensin II-induced Nuclear Factor-Kappab Activation and Bone Morphogenetic Protein-2 Downregulation in Rat Vascular Smooth Muscle Cells.

[Protective mechanism of tetramethylpyrazine on cardiovascular system]

Ultrasound-enhanced protective effect of tetramethylpyrazine against cerebral ischemia/reperfusion injury.

[Mechanism of tetramethylpyrazine attenuates inflammatory injury in endothelial cells by activating the SIRT1 signaling pathway]

Tetramethylpyrazine Identified by a Network Pharmacology Approach Ameliorates Methotrexate-Induced Oxidative Organ Injury

Ultrasound-Enhanced Protective Effect of Tetramethylpyrazine Against Cerebral Ischemia/Reperfusion Injury